Please login to the form below

Not currently logged in
Email:
Password:

Webinars

  • Transforming Access to Medicines Through Patient-Centric Solutions

    Thursday, 14 December 2017 - 2:00 pm

    As medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are operating optimally.

    Dominic Tyer, Editorial director

    FREE | REGISTER NOW

  • The Future of Marketing in Life Sciences: Is your function fit for purpose

    Thursday, 30 November 2017 - 2:00 pm

    The healthcare landscape is rapidly changing as it responds to a multitude of well-known issues. Coupled with emerging digital technologies, these drivers are shaping the industry, moving it towards a more sophisticated, outcomes-driven model that demands a new approach.

    Dominic Tyer, Editorial director

    FREE | REGISTER NOW

  • The Power of Storytelling in Health: Friend or Foe?

    Wednesday, 15 November 2017 - 3:00 pm

    With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.

    Dominic Tyer, Editorial director

    FREE | REGISTER NOW

  • The Truth about Doctors

    Thursday, 19 October 2017 - 3:00 pm

    ‘The Truth about Doctors’ the first study in the series, aims to get to the heart of the human under the white coat to better understand what motivates doctors and how we can improve the way we communicate to them.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Proving the Strategic Value of Patients

    Tuesday, 10 October 2017 - 3:00 pm

    Patient insights aren’t just a ‘nice to have’: they are essential to understand the space where Pharma’s drugs ‘live’.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Regret Minimisation

    Tuesday, 11 July 2017 - 3:00 pm

    When new products approach the market the level of demand for them is often exaggerated.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Assessing early market opportunity

    Wednesday, 19 April 2017 - 3:00 pm

    To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • PC: Are you Patient Centric or just Politically Correct?

    Tuesday, 24 January 2017 - 3:00 pm

    Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far is it being implemented? Do patients even notice it is happening?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Communicating innovation to payers and policy makers

    Monday, 28 November 2016 - 3:00 pm

    Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Immuno-oncology's evolution: implications for pharma market researche

    Thursday, 17 November 2016 - 3:00 pm

    Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Scale & Strategy: Essential tools for transforming the commercial model

    Wednesday, 9 November 2016 - 2:00 pm

    Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and measured.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Driving adoption of Commercial Analytic solutions Driving adoption of Commercial Analytic solutions

    Tuesday, 25 October 2016 - 3:00 pm

    Measuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities for improvements.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Modelling ‘smart’ and ‘lazy’ thinking to influence decision-making

    Tuesday, 4 October 2016 - 3:00 pm

    Traditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Strengthening market access deliverables by harnessing the patient journey

    Wednesday, 14 September 2016 - 3:00 pm

    In today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • The value of early asset development and commercialisation

    Wednesday, 13 July 2016 - 3:00 pm

    Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets to succeed.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Developing medical education that advances patient outcomes

    Thursday, 30 June 2016 - 2:00 pm

    As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in clinical practice and advancing patient outcomes.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Customer engagement design in pharma

    Thursday, 19 May 2016 - 3:00 pm

    In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years might not be the right one for the future.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Rare diseases: Regulatory and reimbursement submissions, the challenges

    Tuesday, 22 March 2016 - 3:00 pm

    Companies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Meaningful digital initiatives need face time

    Wednesday, 10 February 2016 - 3:00 pm

    Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Authentic Engagement in Healthcare thumb Authentic Engagement in Healthcare

    Tuesday, 24 November 2015 - 2:00 pm

    What does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

Previous 1 2 3 Next

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

At M&F Health we deliver real and lasting impact for our clients.We specialise in health and wellbeing, education and environment,...

Latest intelligence

Shining a light on the true cost of patient care
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS...
city
The real-world data conundrum
How data is changing the healthcare industries...
Where is health behaviour change heading?
Cures rely on patient adherence to succeed, and health behaviour change in any non-compliant patient is essential, this post explores where health behaviour change is heading....

Infographics